These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
180 related articles for article (PubMed ID: 11502527)
21. Effect of temafloxacin on the pharmacokinetics of theophylline. Ruff F; Santais MC; Callens E; Chauvin JP; Hazebroucq J Am J Med; 1991 Dec; 91(6A):76S-80S. PubMed ID: 1662899 [TBL] [Abstract][Full Text] [Related]
22. Simultaneous pharmacokinetics evaluation of human cytochrome P450 probes, caffeine, warfarin, omeprazole, metoprolol and midazolam, in common marmosets (Callithrix jacchus). Uehara S; Inoue T; Utoh M; Toda A; Shimizu M; Uno Y; Sasaki E; Yamazaki H Xenobiotica; 2016; 46(2):163-8. PubMed ID: 26114209 [TBL] [Abstract][Full Text] [Related]
23. Absence of an effect of levofloxacin on warfarin pharmacokinetics and anticoagulation in male volunteers. Liao S; Palmer M; Fowler C; Nayak RK J Clin Pharmacol; 1996 Nov; 36(11):1072-7. PubMed ID: 8973996 [TBL] [Abstract][Full Text] [Related]
25. Effect of trovafloxacin, a new fluoroquinolone antibiotic, on the steady-state pharmacokinetics of theophylline in healthy volunteers. Vincent J; Teng R; Dogolo LC; Willavize SA; Friedman HL J Antimicrob Chemother; 1997 Jun; 39 Suppl B():81-6. PubMed ID: 9222075 [TBL] [Abstract][Full Text] [Related]
27. Inhibition of drug metabolism by quinolone antibiotics. Edwards DJ; Bowles SK; Svensson CK; Rybak MJ Clin Pharmacokinet; 1988 Sep; 15(3):194-204. PubMed ID: 3052987 [TBL] [Abstract][Full Text] [Related]
28. Interaction between the fluoroquinolones and the bronchodilator theophylline. Wijnands WJ; Vree TB J Antimicrob Chemother; 1988 Sep; 22 Suppl C():109-14. PubMed ID: 3053575 [TBL] [Abstract][Full Text] [Related]
29. Age-related changes of hepatic clearances of cytochrome P450 probes, midazolam and R-/S-warfarin in combination with caffeine, omeprazole and metoprolol in cynomolgus monkeys using in vitro-in vivo correlation. Koyanagi T; Nakanishi Y; Murayama N; Yamaura Y; Ikeda K; Yano K; Uehara S; Utoh M; Kim S; Uno Y; Yamazaki H Xenobiotica; 2015 Apr; 45(4):312-21. PubMed ID: 25364857 [TBL] [Abstract][Full Text] [Related]
30. Evaluation of disease-mediated therapeutic protein-drug interactions between an anti-interleukin-6 monoclonal antibody (sirukumab) and cytochrome P450 activities in a phase 1 study in patients with rheumatoid arthritis using a cocktail approach. Zhuang Y; de Vries DE; Xu Z; Marciniak SJ; Chen D; Leon F; Davis HM; Zhou H J Clin Pharmacol; 2015 Dec; 55(12):1386-94. PubMed ID: 26054042 [TBL] [Abstract][Full Text] [Related]
31. The impact of acute phase response on the plasma clearance of antipyrine, theophylline, phenytoin and nifedipine in rabbits. Saitoh T; Kokue E; Shimoda M J Vet Pharmacol Ther; 2000 Jun; 23(3):153-8. PubMed ID: 11110102 [TBL] [Abstract][Full Text] [Related]
32. Pharmacokinetics and inflammatory fluid penetration of clinafloxacin. Wise R; Jones S; Das I; Andrews JM Antimicrob Agents Chemother; 1998 Feb; 42(2):428-30. PubMed ID: 9527799 [TBL] [Abstract][Full Text] [Related]
33. Ecological disturbances in intestinal microflora caused by clinafloxacin, an extended-spectrum quinolone. Oh H; Nord CE; Barkholt L; Hedberg M; Edlund C Infection; 2000 Sep; 28(5):272-7. PubMed ID: 11073132 [TBL] [Abstract][Full Text] [Related]